27th Jan 2006 12:48
Pfizer Statement on Status of Exubera Filing in the U.S. NEW YORK, Jan. 27 -- Pfizer Inc said today that Exubera (inhaled human insulin powder) has been approved by the European Commission but has not yet been approved by the U.S. Food and Drug Administration. The company expects that the FDA will issue a decision concerning Exubera shortly. Pfizer regrets an incorrect statement it made to CNBC about the regulatory status of Exubera in the U.S. and is correcting it with CNBC. Information about the approval of Exubera by the European Commission is available at http://www.pfizer.com. SOURCE Pfizer Inc 01/27/2006 /CONTACT: Andy McCormick, +1-212-733-5469/ /Company News On-Call: Pfizer's press releases are available through PR Newswire's Company News On-Call service on PRN's Web Site. Visit http://www.prnewswire.com/comp/688250.html / /Photo: A free corporate logo to accompany this story is available immediately via Wieck Photo Database to any media with telephoto receiver or electronic darkroom, PC or Macintosh, that can accept overhead transmissions. To retrieve a logo, please call 972-392-0888./ /Company News On-Call: http://www.prnewswire.com/comp/688250.html / /Web site: http://www.pfizer.com / (PFE) ENDPFIZER INCRelated Shares:
PFZ.L